Up next

Autoplay

Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron

1 Views • 06/15/23
Share
Embed
administrator
administrator
Subscribers
0

A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay